Compare Medpace Holdings Inc (MEDP) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Seagate Technology Holdings PLC — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Seagate Technology Holdings PLC trades at $783 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 10.5× Medpace Holdings Inc's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Seagate Technology Holdings PLC for 41 Days on average.
| MEDP | STX | |
|---|---|---|
Market Cap | $16.82B | $176.19B |
Volume | 223,093 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $630.19 | $1.09K |
52-Week Low | $393.42 | $211.63 |
Typical Hold Time | 14 Days | 41 Days |
Enterprise Value | $16.44B | $178.34B |
Dividend Yield | — | 0.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
STX trades at $783, down 3.01% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10, and robust profitability metrics including 26.11% net income margin. Technical indicators are bearish with price near pivot point support at $782, while analyst consensus remains positive with 54% buy ratings and $1,130 price target.
Despite near-term competitive pressures, STX maintains strong AI-driven storage demand positioning. Investment opportunity lies in the company's record margins and nearly sold-out capacity, though risks include potential pricing pressure from increased industry supply and high valuation multiples that may limit upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
